Programmed Cell Death in Cystinosis

Cells. 2022 Feb 15;11(4):670. doi: 10.3390/cells11040670.

Abstract

Cystinosis is a lethal autosomal recessive disease that has been known clinically for over 100 years. There are now specific treatments including dialysis, renal transplantation and the orphan drug, cysteamine, which greatly improve the duration and quality of patient life, however, the cellular mechanisms responsible for the phenotype are unknown. One cause, programmed cell death, is clearly involved. Study of extant literature via Pubmed on "programmed cell death" and "apoptosis" forms the basis of this review. Most of such studies involved apoptosis. Numerous model systems and affected tissues in cystinosis have shown an increased rate of apoptosis that can be partially reversed with cysteamine. Proposed mechanisms have included changes in protein signaling pathways, autophagy, gene expression programs, and oxidative stress.

Keywords: apoptosis; cystinosis; programmed cell death.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Autophagy
  • Cysteamine / pharmacology
  • Cysteamine / therapeutic use
  • Cystinosis*
  • Humans
  • Kidney Transplantation*

Substances

  • Cysteamine